Le Lézard

Countable Labs Announces Additional Modules for Countable PCR Expanding its Utility for Translational Research, Cell and Gene Therapy Manufacturing, and Diagnostic Development

Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
The Lancet

Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort stu…

Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...
Le Lézard

Point-of-Care Molecular Diagnostics Market Surges to USD 15.2 Billion by 2033, Propelled by 10.2% CAGR - Verified Market Reports®

The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...

Gut microbiome tests are everywhere. Should you get one?

At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed ...
The Lancet

Lessons from Africa: health diplomacy in HIV prevention

In these uncertain, volatile, and unprecedented times, the role of science is more important than ever. Scientific advances that benefit humanity and ensure planetary sustainability for current and ...